Mispro to Open Contract Vivarium in Philadelphia’s UCity Biocluster
With the emergence of Coronavirus COVID-19, Mispro Biotech Services has taken multiple measures to ensure the safety of our staff, our research environments, and the research models in our facilities.
We have contacted each of our clients directly to notify them of temporary changes to protocols in regards to facility access and operations that will enable them to continue to work, yet mitigate risk of human exposure to COVID-19. If you would like more information, please email us at COVIDinfo@mispro.com.
We have implemented a contingency plan for our on-site employees that will provide uninterrupted animal care and veterinary oversight to ensure the health & safety of the research models in our facilities.
We are accepting new clients in our research facilities in all locations where space is available. We know your research timelines are important and we promise open, clear & honest communication about how we can support the launch of your in vivo studies in our facilities. For questions, please email us.
We appreciate your trust & cooperation during this unprecedented situation and will notify you immediately of any changes.
.png)
